FR2008048A1 - - Google Patents
Info
- Publication number
- FR2008048A1 FR2008048A1 FR6914547A FR6914547A FR2008048A1 FR 2008048 A1 FR2008048 A1 FR 2008048A1 FR 6914547 A FR6914547 A FR 6914547A FR 6914547 A FR6914547 A FR 6914547A FR 2008048 A1 FR2008048 A1 FR 2008048A1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/12—Triazine radicals
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS339968 | 1968-05-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR2008048A1 true FR2008048A1 (US08058424-20111115-C00008.png) | 1970-01-16 |
Family
ID=5373920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR6914547A Pending FR2008048A1 (US08058424-20111115-C00008.png) | 1968-05-08 | 1969-05-07 |
Country Status (12)
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2085707A1 (US08058424-20111115-C00008.png) * | 1970-03-14 | 1971-12-31 | Schering Ag | |
| WO2008044041A1 (en) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
| WO2008044045A1 (en) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6905669B2 (en) | 2001-04-24 | 2005-06-14 | Supergen, Inc. | Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase |
| US6982253B2 (en) | 2002-06-05 | 2006-01-03 | Supergen, Inc. | Liquid formulation of decitabine and use of the same |
| US6887855B2 (en) | 2003-03-17 | 2005-05-03 | Pharmion Corporation | Forms of 5-azacytidine |
| US6943249B2 (en) | 2003-03-17 | 2005-09-13 | Ash Stevens, Inc. | Methods for isolating crystalline Form I of 5-azacytidine |
| US7038038B2 (en) | 2003-03-17 | 2006-05-02 | Pharmion Corporation | Synthesis of 5-azacytidine |
| US20060014949A1 (en) * | 2004-07-13 | 2006-01-19 | Supergen Inc. | Compositions and formulations of decitabine polymorphs and methods of use thereof |
| US7250416B2 (en) | 2005-03-11 | 2007-07-31 | Supergen, Inc. | Azacytosine analogs and derivatives |
| US7700567B2 (en) | 2005-09-29 | 2010-04-20 | Supergen, Inc. | Oligonucleotide analogues incorporating 5-aza-cytosine therein |
| SG193206A1 (en) | 2008-05-15 | 2013-09-30 | Celgene Corp | Oral formulations of cytidine analogs and methods of use thereof |
| JP5650643B2 (ja) | 2008-08-08 | 2015-01-07 | サイノファーム タイワン リミテッド | ５−アザシトシンヌクレオシド及びその誘導体の製造方法 |
| US9951098B2 (en) | 2011-03-31 | 2018-04-24 | Pharmion Llc | Synthesis of 5-azacytidine |
| CN103945902B (zh) | 2011-08-30 | 2018-07-20 | 阿斯泰克斯制药公司 | 地西他滨衍生物制剂 |
| CA2991167A1 (en) | 2015-07-02 | 2017-01-05 | Otsuka Pharmaceutical Co., Ltd. | Lyophilized pharmaceutical compositions |
| WO2017090264A1 (ja) | 2015-11-27 | 2017-06-01 | 大原薬品工業株式会社 | ５－アザシチジン又は其の２'－デオキシ体の５'位ジベンジル燐酸エステル |
| US10227374B2 (en) | 2016-04-21 | 2019-03-12 | Ohara Pharmaceutical Co., Ltd. | Silyl etherified derivatives of 5-azacytidines in carbohydrate moiety |
| WO2017183215A1 (ja) | 2016-04-21 | 2017-10-26 | 大原薬品工業株式会社 | ５－アザシチジン類の糖部シリルエーテル誘導体 |
| JP6162349B1 (ja) | 2016-04-21 | 2017-07-12 | 大原薬品工業株式会社 | ５−アザシチジン類の糖部シリルエーテル誘導体 |
| MX2020001233A (es) | 2017-08-03 | 2020-07-20 | Otsuka Pharma Co Ltd | Compuesto farmaceutico y metodos de purificacion del mismo. |
-
1969
- 1969-04-23 CH CH619669A patent/CH527207A/de not_active IP Right Cessation
- 1969-04-24 GB GB1227691D patent/GB1227691A/en not_active Expired
- 1969-04-29 IT IT1620369A patent/IT1037009B/it active
- 1969-04-29 BE BE732268D patent/BE732268A/xx unknown
- 1969-05-03 DE DE19691922702 patent/DE1922702A1/de active Pending
- 1969-05-06 NL NL6906909A patent/NL6906909A/xx unknown
- 1969-05-07 ES ES366910A patent/ES366910A1/es not_active Expired
- 1969-05-07 FR FR6914547A patent/FR2008048A1/fr active Pending
- 1969-05-07 AT AT439269A patent/AT306930B/de not_active IP Right Cessation
- 1969-05-07 BR BR20860069A patent/BR6908600D0/pt unknown
- 1969-05-08 JP JP3545969A patent/JPS4916435B1/ja active Pending
- 1969-05-08 CA CA050902A patent/CA921904A/en not_active Expired
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2085707A1 (US08058424-20111115-C00008.png) * | 1970-03-14 | 1971-12-31 | Schering Ag | |
| WO2008044041A1 (en) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
| WO2008044045A1 (en) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1227691A (US08058424-20111115-C00008.png) | 1971-04-07 |
| IT1037009B (it) | 1979-11-10 |
| JPS4916435B1 (US08058424-20111115-C00008.png) | 1974-04-22 |
| AT306930B (de) | 1973-04-25 |
| NL6906909A (US08058424-20111115-C00008.png) | 1969-11-11 |
| BE732268A (US08058424-20111115-C00008.png) | 1969-10-01 |
| ES366910A1 (es) | 1971-03-16 |
| DE1922702A1 (de) | 1969-11-20 |
| CH527207A (de) | 1972-08-31 |
| BR6908600D0 (pt) | 1973-02-22 |
| CA921904A (en) | 1973-02-27 |
